RA
CSII

Royce & Associates’s Cardiovascular Systems, Inc. CSII Stock Holding History

Royce & Associates’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-77,117
Closed -$3.31M – 1195
2019
Q2 		$3.31M Sell
77,117
-2,727
-3% -$106K 0.03% 601
2019
Q1 		$3.09M Buy
79,844
+45,000
+129% +$1.53M 0.03% 619
2018
Q4 		$993K Buy
+34,844
New +$1.11M 0.01% 864

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates's CSII Position: Q3 2019 in Review

Royce & Associates sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2019, closing a stake of 77,117 shares — an estimated $3.31M sold.

Royce & Associates first reported a position in CSII in Q4 2018 and held it in 3 quarters. The position peaked at $3.31M in Q2 2019. 190 funds tracked by Wall St. Rank hold CSII as of Q3 2019.

  • Royce & Associates reported no remaining Cardiovascular Systems, Inc. position as of Q3 2019 after selling out during the quarter.
  • Royce & Associates sold 77,117 Cardiovascular Systems, Inc. shares in Q3 2019, an estimated $3.31M.
  • Royce & Associates first reported a position in Cardiovascular Systems, Inc. in Q4 2018 and held it in 3 quarters.
  • Royce & Associates's Cardiovascular Systems, Inc. position peaked at $3.31M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2019.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.